PD-1/PD-L1 pathway: current researches in cancer.

By Yanyan Han, Dandan Liu, Lianhong Li. American Journal of Cancer Research, 2020

1,604 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/095b92ea19d5bcf1acddabdcb47a39bfcdd2d568

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Y. Shiravand
2. R. Ladwa
3. K. O'Byrne
4. S. R. Hosseini-Fard
5. Faezeh Khodadadi
6. Seyyed Mohammad Amin Kashani
7. H. Sadeghirad
8. Shadi Hosseini

Citations in the corpus

• Immune Checkpoint Inhibitors in Cancer Therapy (2022, background): “The expression of PD-1 has been detected on various types of immune cell within TME, including activated monocytes, dendritic cells (DCs), natural killer (NK) cells, and T cells as well as B cells [33].”